Stocks and Investing Stocks and Investing
Tue, December 1, 2020
Mon, November 30, 2020

Matthew Harrison Maintained (ABBV) at Buy with Increased Target to $120 on, Nov 30th, 2020


Published on 2024-10-27 14:53:41 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $108 to $120 on, Nov 30th, 2020.

Matthew has made no other calls on ABBV in the last 4 months.



There are 6 other peers that have a rating on ABBV. Out of the 6 peers that are also analyzing ABBV, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Matthew


  • Gary Nachman of "BMO Capital" Initiated at Buy and Held Target at $123 on, Wednesday, November 18th, 2020
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $119 on, Monday, November 2nd, 2020
  • Andrew Baum of "Citigroup" Maintained at Strong Buy with Increased Target to $105 on, Wednesday, September 2nd, 2020
  • David Risinger of "Morgan Stanley" Maintained at Buy with Increased Target to $108 on, Thursday, August 20th, 2020
  • Randall Stanicky of "RBC Capital" Maintained at Buy with Increased Target to $127 on, Monday, August 3rd, 2020
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $111 on, Monday, August 3rd, 2020
Contributing Sources